Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo

Basic and Clinical Pharmacology and Toxicology

Volumn 115, Issue 1, 2014, Pages 118-128

  Bonefeld Jørgensen, Eva C ^a   Ghisari, Mandana ^a   Wielsøe, Maria ^a   Bjerregaard Olesen, Christian ^a   Kjeldsen, Lisbeth S ^a   Long, Manhai ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BIOLOGICAL MARKER; ENDOCRINE DISRUPTOR; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; POLLUTANT; POLYCHLORINATED BIPHENYL; POLYCHLORODIBENZO-4-DIOXIN; XENOBIOTIC AGENT;

ARTICLE; BIOACCUMULATION; BIOLOGICAL MONITORING; CELL FUNCTION; DRUG BLOOD LEVEL; ENVIRONMENTAL EXPOSURE; EX VIVO STUDY; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; PERSISTENT ORGANIC POLLUTANT; POLLUTANT; PRIORITY JOURNAL; RISK FACTOR; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; ENVIRONMENTAL MONITORING; PROCEDURES; TOXICITY;

ANIMALIA;

ANIMALS; BIOMARKERS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS; POLYCHLORINATED BIPHENYLS; TETRACHLORODIBENZODIOXIN; XENOBIOTICS;

EID: 84902119458     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12263     Document Type: Article

References (94)

1. Ritter R, Scheringer M, MacLeod M, Moeckel C, Jones KC, Hungerbuhler K. Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom. Environ Health Perspect 2011;119:225-31.
2. Kruger T, Ghisari M, Long M, Bonefeld-Jorgensen EC. Biomarkers used in environmental health with focus on endocrine disrupters. In: Friis RH (ed.). The Praeger Handbook of Environmental Health. Praeger 1, Santa Barbra, California, USA, Chapter 13, 2012;259-79.
3. Ghisari M, Kruger T, Long M, Bonefeld-Jorgensen EC. Biomarkers of effects on hormone functions. In: Knudsen LE, Merlo DF (eds). Biomarkers and Human Biomonitoring, Vol. 2. The Royal Society of Chemistry, Cambridge, UK, chapter 10, 2012;142-59.
4. (IPCS) IPoCS. Global assessment of the state-of-the-science of endocrine disruptors. In: Damstra T, Barlow S, Bergman A, Kavlock R, van der Kraak G (eds). Chapter 1. World Health Organization, Geneva, 2002; 1, http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/ (last accessed on 19 May 2014).
5. Yang M, Park MS, Lee HS. Endocrine disrupting chemicals: human exposure and health risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24:183-224.
6. Rosenmai AK, Nielsen FK, Pedersen M, Hadrup N, Trier X, Christensen JH et al. Fluorochemicals used in food packaging inhibit male sex hormone synthesis. Toxicol Appl Pharmacol 2013;266:132-42.
7. Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM. Endocrine disrupting potentials of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol and 4-n-octylphenol in vitro-new data and a brief review. Environ Health Perspect 2007;115:69-76.
8. Kjeldsen LS, Bonefeld-Jorgensen EC. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int 2013;20:8031-44.
9. Ohtake F, Fujii-Kuriyama Y, Kawajiri K, Kato S. Cross-talk of dioxin and estrogen receptor signals through the ubiquitin system. J Steroid Biochem Mol Biol 2011;127:102-7.
10. Murphy KA, Quadro L, White LA. The intersection between the aryl hydrocarbon receptor (AhR)- and retinoic acid-signaling pathways. Vitam Horm 2007;75:33-67.
11. Kruger T, Long M, Bonefeld-Jorgensen E. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology 2008;246:112-23.
12. Long M, Krüger T, Ghisari M, Bonefeld-Jørgensen EC. Effects of selected phytoestrogens and their mixtures on the function of the thyroid hormone and the aryl hydrocarbon receptor. Nutr Cancer 2012;64:1008-19.
13. Dewailly E, Ayotte P, Bruneau S, Laliberte C, Muir DC, Norstrom RJ. Inuit exposure to organochlorines through the aquatic food chain in Arctic Quebec. Environ Health Perspect 1993;101:618-20.
14. Barrie LA, Gregor D, Hargrave B, Lake R, Muir D, Shearer R et al. Arctic contaminants: sources, occurrence and pathways. Sci Total Environ 1992;122:1-74.
15. Macdonal RW, Barrie LA, Bidleman TF, Diamond ML, Gregor DJ, Semkin RG et al. Contaminants in the Canadian Arctic: 5 years of progress in understanding sources, occurrence and pathways. Sci Total Environ 2000;254:93-234.
16. Van Oostdam JC, Dewailly E, Gilman A, Hansen JC, Odland JO, Chashchin V et al. Circumpolar maternal blood contaminant survey, 1994-1997 organochlorine compounds. Sci Total Environ 2004;330:55-70.
17. Stockholmconvention. Fourth meeting of the conference of the parties of the Stockholm convention. Secondary fourth meeting of the conference of the parties of the Stockholm convention 2009-2014. http://chm.pops.int/ (last accessed on 1 February 2014).
18. Riget F, Bignert A, Braune B, Stow J, Wilson S. Temporal trends of legacy POPs in Arctic biota, an update. Sci Total Environ 2010;408:2874-84.
19. Bjerregaard P, Pedersen HS, Nielsen NO, Dewailly E. Population surveys in Greenland 1993-2009: temporal trend of PCBs and pesticides in the general Inuit population by age and urbanisation. Sci Total Environ 2013;454-455:283-8.
20. Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Fed Proc 1970;29:1699-703.
21. Dimitrov S, Kamenska V, Walker JD, Windle W, Purdy R, Lewis M et al. Predicting the biodegradation products of perfluorinated chemicals using CATABOL. SAR QSAR Environ Res 2004;15:69-82.
22. Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001;35:1339-42.
23. Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ Sci Technol 2008;42:4989-95.
24. Giesy JP, Kannan K, Jones PD. Global biomonitoring of perfluorinated organics. ScientificWorldJournal 2001;1:627-9.
25. OECD. Hazard Assessment of Perfluorooctane Sulfonate and Its Salts. OECD, ENV/JM/EXCH, 8, Paris, France, 2002. http://www.oecd.org/dataoecd/23/18/2382880.pdf (last accessed on 21 November 2002).
26. AMAP. Assessment Report: Arctic Pollution Issues. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway, 1998;xii + 859 pp.
27. AMAP. Toxicological Properties of Persistent Organic Pollutants and Related Health Effects of Concern for the Arctic Populations, Chapter 6 AMAP Assessment 2002: Persistent Organic Pollutants in the Arctic. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway, xiv + 137 pp, 2002;57-74.
28. Bonefeld-Jorgensen EC. Genetics and Contaminants, Chapter 6 in AMAP Assessment 2009: Human Health in the Arctic. Arctic Monitoring and Assessment Programmme (AMAP), Oslo, Norway, 2009. www.amap.no (last accessed on 1 June 2009).
29. Bonefeld-Jorgensen EC. Biomonitoring in Greenland: human biomarkers of exposure and effects - a short review. Rural Remote Health 2010;10:1362.
30. Van Oostdam J, Donaldson SG. Human tissue levels of environmental contaminants. In: (AMAP) AMaAP (ed.). AMAP Assessment 2009: Human Health in the Arctic. Oslo, Norway, 2009. http://www.amap.no/ (last accessed on 1 June 2009).
31. Cote S, Dodin S, Blanchet C, Mulvad G, Pedersen HS, Blanchet C et al. Very high concentrations of n-3 fatty acids in peri- and postmenopausal Inuit women from Greenland. Int J Circumpolar Health 2004;63(Suppl 2):298-301.
32. Deutch B, Pedersen HS, Jorgensen EC, Hansen JC. Smoking as a determinant of high organochlorine levels in Greenland. Arch Environ Health 2003;58:30-6.
33. Deutch B, Pedersen HS, Hansen JC. Dietary composition in Greenland 2000, plasma fatty acids and persistent organic pollutants. Sci Total Environ 2004;331:177-88.
34. Deutch B, Dyerberg J, Pedersen HS, Aschlund E, Hansen JC. Traditional and modern Greenlandic food - dietary composition, nutrients and contaminants. Sci Total Environ 2007;384:106-19.
35. Deutch B, Hansen JC. High human plasma levels of organochlorine compounds in Greenland. Regional differences and lifestyle effects. Dan Med Bull 2000;47:132-7.
36. Kruger T, Long M, Ghisari M, Bonefeld-Jorgensen EC. The combined effect of persistent organic pollutants in the serum POP mixture in Greenlandic Inuit: xenoestrogenic, xenoandrogenic and dioxin-like transactivities. Biomarkers 2012;17:692-705.
37. Riget F, Dietz R, Vorkamp K, Johansen P, Muir D. Levels and spatial and temporal trends of contaminants in Greenland biota: an updated review. Sci Total Environ 2004;331:29-52.
38. Vorkamp K, Christensen JH, Glasius M, Riget FF. Persistent halogenated compounds in black guillemots (Cepphus grylle) from Greenland-levels, compound patterns and spatial trends. Mar Pollut Bull 2004;48:111-21.
39. Dewailly E, Mulvad G, Pedersen HS, Ayotte P, Demers A, Weber JP et al. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ Health Perspect 1999;107:823-8.
40. Sonne C, Gustavson K, Riget FF, Dietz R, Kruger T, Bonefeld-Jorgensen EC. Physiologically based pharmacokinetic modeling of POPs in Greenlanders. Environ Int 2013;64C:91-7.
41. Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM. Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 2001;158:141-53.
42. Payne J, Scholze M, Kortenkamp A. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ Health Perspect 2001;109:391-7.
43. Rajapakse N, Silva E, Kortenkamp A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 2002;110:917-21.
44. Metzdorff SB, Dalgaard M, Christiansen S, Axelstad M, Hass U, Kiersgaard MK et al. Dysgenesis and histological changes of genitals and perturbations of gene expression in male rats after in utero exposure to antiandrogen mixtures. Toxicol Sci 2007;98:87-98.
45. Bonefeld-Jorgensen EC, Hjelmborg PS, Reinert TS, Andersen BS, Lesovoy V, Lindh CH et al. Xenoestrogenic activity in blood of European and Inuit populations. Environ Health 2006;5:12.
46. Krüger T, Hjelmborg PS, Jönsson BAG, Hagmar L, Giwercman A, Manicardi G-C et al. Xeno-androgenic activity in serum differs across European and Inuit populations. Environ Health Perspect 2007;115:21-7.
47. Long M, Andersen BS, Lindh CH, Hagmar L, Giwercman A, Manicardi GC et al. Dioxin-like activities in serum across European and Inuit populations. Environ Health 2006;5:14.
48. Hjelmborg PS, Ghisari M, Bonefeld-Jorgensen EC. SPE-HPLC purification of endocrine-disrupting compounds from human serum for assessment of xenoestrogenic activity. Anal Bioanal Chem 2006;385:875-87.
49. Rasmussen TH, Nielsen F, Andersen HR, Nielsen JB, Weihe P, Grandjean P. Assessment of xenoestrogenic exposure by a biomarker approach: application of the E-Screen bioassay to determine estrogenic response of serum extracts. Environ Health 2003;2:12.
50. Kruger T, Ghisari M, Hjelmborg PS, Deutch B, Bonefeld-Jorgensen EC. Xenohormone transactivities are inversely associated to serum POPs in Inuit. Environ Health 2008;7:38.
51. Long M, Deutch B, Bonefeld-Jørgensen EC. AhR transcriptional activity in serum of Inuits across Greenlandic districts. Environ Health 2007;6:1-17.
52. Fernandez MF, Rivas A, Olea-Serrano F, Cerrillo I, Molina-Molina JM, Araque P et al. Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect. Anal Bioanal Chem 2004;379:163-70.
53. Ibarluzea JMJ, Fernandez MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ et al. Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control 2004;15:591-600.
54. Rivas A, Fernandez MF, Cerrillo I, Ibarluzea J, Olea-Serrano MF, Pedraza V et al. Human exposure to endocrine disrupters: standardisation of a marker of estrogenic exposure in adipose tissue. APMIS 2001;109:185-97.
55. Erdmann SE, Dietz R, Sonne C, Bechshoft TO, Vorkamp K, Letcher RJ et al. Xenoestrogenic and dioxin-like activity in blood of East Greenland polar bears (Ursus maritimus). Chemosphere 2013;92:583-91.
56. Bonefeld-Jorgensen EC, Long M. Dioxin-like activity in the blood of Greenlandic Inuit and Danish women: a pilot study. Int J Circumpolar Health 2010;69:181-94.
57. Mørck TA, Erdmann SE, Long M, Mathiesen M, Nielsen F, Siersma VD et al. PCB concentrations and dioxin-like activity in serum samples from Danish school children and their mothers living in urban and rural areas. Basic Clin Pharmacol Toxicol 2014; 115:134-44.
58. AMAP. AMAP Assessment 2009: Human Health in the Arctic. Arctic Monitoring and Assessment Programmme (AMAP), Oslo, Norway, 2009.
59. Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L et al. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncol 2013;14:287-8.
60. Bonefeld-Jørgensen EC, Ayotte P. Toxicological properties of POPs and related health effects of concern for the Arctic populations, chapter 6. In: AMAP (ed.). AMAP Assessment 2002: Human Health in the Arctic. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway, xiv + 137 pp, 2003;57-73. www.amap.no (last accessed on 1 June 2004).
61. Ghisari M, Long M, Bonefeld-Jorgensen EC. Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans. Int J Circumpolar Health 2013;72:21113.
62. Fredslund SO, Bonefeld-Jorgensen EC. Breast cancer in the Arctic-changes over the past decades. Int J Circumpolar Health 2012;71:19155.
63. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T et al. Perfluorinated compounds are related to breast cancer risk in greenlandic inuit: a case control study. Environ Health 2011;10:88.
64. Ghisari M, Eiberg H, Long M, Bonefeld-Jorgensen EC. Polymorphisms in Phase I and Phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health 2014;13:19.
65. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ Health Perspect 2008;116:1547-52.
66. Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 2006;40:3463-73.
67. Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int J Hyg Environ Health 2009;212:239-70.
68. Eriksen KT, Sorensen M, McLaughlin JK, Tjonneland A, Overvad K, Raaschou-Nielsen O. Determinants of plasma PFOA and PFOS levels among 652 Danish men (dagger). Environ Sci Technol 2011;49:8137-43.
69. Fei C, McLaughlin JK, Tarone RE, Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007;115:1677-82.
70. Rylander C, Sandanger TM, Froyland L, Lund E. Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study. Environ Sci Technol 2010;44:5225-32.
71. Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect 2008;116:1391-5.
72. Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 2009;24:1200-5.
73. Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding. Scand J Work Environ Health 2010;36:413-21.
74. Fei C, McLaughlin JK, Tarone RE, Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 2008;168:66-72.
75. Long M, Bossi R, Bonefeld-Jorgensen EC. Level and temporal trend of perfluoroalkyl acids in Greenlandic Inuit. Int J Circumpolar Health 2011;71:17998.
76. Ghisari M, Eiberg H, Long M, Bonefeld-Jørgensen EC. Polymorphisms in Phase I and Phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health 2014;13:19.
77. Kennedy GL Jr, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 2004;34:351-84.
78. Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH et al. Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 2004;39:363-80.
79. Andersen ME, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL Jr, Lau C et al. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 2008;102:3-14.
80. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007;99:366-94.
81. Fuentes S, Vicens P, Colomina MT, Domingo JL. Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology 2007;242:123-9.
82. Johansson N, Eriksson P, Viberg H. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 2009;108:412-8.
83. U.S. EPA. Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts. U.S. EPA SAB, May 30, 2006, U.S.EPA public docket EPA-SAB-06-006, Washington, DC, 2006.
84. Sibinski LJ. Final Report of a Two Year Oral (Diet) Toxicity and Carcinogenicity Study of Fluorochemical FC-143 (Perfluorooctanane Ammonium Carboxylate) in Rats. 3M Company/RIKER Exp. No. 0281CR0012; 8EHQ-1087-0394, 1987;1-4.
85. Hardisty JF, Willson GA, Brown WR, McConnell EE, Frame SR, Gaylor DW et al. Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years. Drug Chem Toxicol 2010;33:131-7.
86. Butenhoff JL, Kennedy GL Jr, Chang SC, Olsen GW. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 2012;298:1-13.
87. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 2007;96:133-44.
88. Kropp T, Houlihan J. Evaluating human health risks from exposure to perfluorooctanoic acid (PFOA): recommendations to the Science Advisory Board's PFOA Review Panel. Presented February 10, 2005 to the US EPA Science Advisory Board's PFOA Review Panel, in Washington, DC, 2005.
89. Maras M, Vanparys C, Muylle F, Robbens J, Berger U, Barber JL et al. Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Environ Health Perspect 2006;114:100-5.
90. Long M, Ghisari M, Bonefeld-Jorgensen EC. Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int 2013;20:8045-56.
91. Eriksen KT, Raaschou-Nielsen O, Sorensen M, Roursgaard M, Loft S, Moller P. Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat Res 2010;700:39-43.
92. Florentin A, Deblonde T, Diguio N, Hautemaniere A, Hartemann P. Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: cytotoxicity but no genotoxicity? Int J Hyg Environ Health 2011;214:493-9.
93. Yao X, Zhong L. Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res 2005;587:38-44.
94. Huang Q, Zhang J, Martin FL, Peng S, Tian M, Mu X et al. Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. Toxicol Lett 2013;223:211-20.